Accumulation of amyloid-β (Aβ) in synaptic mitochondria is associated with mitochondrial and synaptic injury. The underlying mechanisms and strategies to eliminate Aβ and rescue mitochondrial and synaptic defects remain elusive. Presequence protease (PreP), a mitochondrial peptidasome, is a novel mitochondrial Aβ degrading enzyme. Here, we demonstrate for the first time that increased expression of active human 
Introduction
Mitochondrial and synaptic dysfunctions are the early pathological features of Alzheimer's disease-affected brain. Amyloid-β peptide (Aβ) has deleterious effects on mitochondrial functions and contributes to energy failure, respiratory chain impairment, neuronal apoptosis, and generation of reactive oxygen species (ROS) in AD brain tissue. Emerging evidence demonstrates a pathological role of intra-mitochondrial Aβ in AD pathogenesis (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) . Aβ progressively accumulates in mitochondria of the AD brain and several transgenic AD mouse models overexpressing Aβ; such accumulation is associated with mitochondrial and neuronal malfunction in AD. Aβ transports directly into mitochondria via translocase of the outer membrane (TOM) machinery (12) , RAGE (receptor for advanced glycation end-products) (13) , or endoplasmic reticulum (ER)-mitochondrial cross-talk (14) . Mitochondrial Aβ may also be locally produced via mitochondria-localized γ-secretase (15, 16) . Accumulation of mitochondrial Aβ precedes extracellular Aβ deposition in the AD brain and increases with age, which is associated with early onset of synaptic loss and mitochondrial oxidative damage (2, 7, 17) . Interaction of mitochondrial Aβ with mitochondrial proteins exacerbates Aβ-induced neuronal stress (6, 8, 18) . Recent studies indicate that mitochondria are also involved in promoting chronic inflammation and leading to cell death (19). Thus, accumulation of Aβ in mitochondria may be an important mechanism leading to neuronal perturbation in AD. Strategies to reduce Aβ levels in mitochondria could open a new avenue for preventing deterioration of mitochondrial function and halting AD progression.
PreP (presequence protease), is a specific mitochondrial peptidasome, localized in mammalian mitochondrial matrix (20) . PreP normally degrades targeting peptides, presequences, which are cleaved off in mitochondria after completion of protein import and other unstructured peptides up to 70 amino acid residues in length (21) . Thus, PreP is a key player in maintenance of mitochondrial health and integrity. In vitro study by Falkevall et al. showed that PreP can degrade various Aβ peptides and is responsible for clearance of mitochondrial Aβ (20, 22) . PreP proteolytic activity is significantly reduced in Aβ-affected brain mitochondria from AD-affected brain and AD transgenic mouse models (22) , which is negatively correlated to mitochondrial Aβ accumulation. Accordingly, Aβ-enriched mitochondria have higher levels of oxidative stress and lower levels of activity of cytochrome c oxidase (22) . We therefore propose that impaired PreP protease function contributes to chronic mitochondrial Aβ accumulation and resultant amyloid pathology as seen in AD-affected brain, including mitochondrial and synaptic degeneration.
The present study is to address the following unexplored questions: Does PreP activity contribute to mitochondrial Aβ accumulation in vivo AD mouse model? If Aβ-loaded mitochondria have increased levels of PreP, will the mitochondrial pool of Aβ decrease, resulting in improved mitochondrial and neuronal function? Does PreP-involved mitochondrial function link to synaptic and cognitive function? Using newly created transgenic (Tg) mice with neuronal expression of human PreP and inactive mutant form of PreP without its proteolytic activity as a control, we comprehensively analyzed the effects of neuronal PreP on synaptic mitochondrial amyloid pathology, mitochondrial function, inflammation, synaptic plasticity, and cognition in a transgenic AD mouse model that overexpresses neuronal Aβ. We provide substantial evidence in vivo that PreP-dependent clearance of mitochondrial Aβ improves synaptic and behavioral functions in AD mouse models.
Results

Generation and characterization of transgenic mice overexpressing neuronal PreP
To evaluate the effect of PreP activity in Aβ-rich environment relevant to the pathophysiology of AD, we first created transgenic mice with selective expression of human PreP in neurons under the control of Thy-1 promoter (PreP mice, Fig. S1A ). We also generated control mice with an inactive mutant PreP (20) in which the catalytic base Glu78 in the inverted zinc-binding motif is replaced by Gln (PE mice) to validate the role of PreP proteolytic activity (Fig. S1B-C) . PreP expression was determined in neuronal mitochondrial (Fig. S1C) , and cytosolic fraction isolated from the transgenic mice (Fig. S1D) . PreP expression levels were significantly increased in neuronal mitochondrial fraction (Fig. S1C) , but not in cytosolic fraction (Fig.   S1D) , from PreP and PE mice as compared to non-transgenic (nonTg) mice, demonstrating that expressed PreP specifically resides in mitochondria. PreP expression levels in PreP mice were comparable to that of PE mice. Immunostaining of brain section with PreP antibody verified that PreP was increased in cortical neurons of both PreP and PE mice (Fig. S1E, green) . To confirm the localization of PreP in mitochondria, we performed confocal and electron microscopic studies in brain tissues. Using confocal microscopy, increased expression of PreP (Fig. S1E, green) is colocalized with cytochrome c oxidase (CCO, red), a mitochondrial protein, in PreP and PE mice (Fig. S1E , merge yellow). Immunogold electron microscopy with gold-conjugated antibody to PreP further verified that specific PreP gold particles were identified in pre-and post-synaptic mitochondria of PreP mice (Fig. S1F) . Accordingly, PreP proteolytic activity was significantly increased in PreP-enriched cortical mitochondria as shown by measuring substrate V degradation ( Fig. S1G) and the enhanced ability for degrading exogenous Aβ compared to those from nonTg or PE mitochondria (Fig. S1H) . As expected, there was no difference in PreP proteolytic activity between nonTg and PE mice To determine the effects of PreP on Aβ-associated mitochondrial defects, Aβ accumulation, and cognitive functions in vivo AD mouse model, PreP or PE mice were crossed with single transgenic mAPP mice to generate double transgenic mAPP/PreP or mAPP/PE mice overexpressing human Aβ and human PreP in neurons. Transgenic mAPP mice overexpressing human Aβ were previously well characterized with respect to mitochondrial function and neuropathological, behavioral and electrophysiological parameters (5, immunogold particles were located in pre-and post-synaptic mitochondria of mAPP/PreP and mAPP/PE mice (Fig. S2B) . These data verify that PreP protein is correctly targeted to mitochondria in PreP-expressed mAPP mice.
Increased neuronal PreP proteolytic activity attenuates synaptic mitochondrial Aβ accumulation
The mitochondrial PreP extracted from mAPP/PreP mice significantly enhanced degradation of Aβ compared to those from mAPP and mAPP/PE mice (Fig. 1A) . The addition of PreP antibody to the mitochondrial lysates from APP/PREP cortical mitochondria containing PreP protein blocked degradation of exogenous Aβ by neutralizing PreP antibody with its antigen PreP protein (Fig. 1A, lane 8 ). As expected, there was no difference in PreP proteolytic activity between mAPP and mAPP/PE mice (Fig. 1A) . This indicates that transgenic mice overexpressing neuronal mitochondrial PreP in Aβ-rich AD mice are appropriate models for the investigation of role of PreP in mitochondrial amyloid pathology and synaptic function.
Next, we examined the effect of PreP overexpression on mitochondrial Aβ accumulation. The synaptic mitochondria were isolated from the cortex of mAPP and mAPP/PreP mice, aged 12 months, an age at which marked mitochondrial Aβ accumulation and mitochondrial defects are observed. The mitochondrial pool of Aβ40 and Aβ42 was significantly reduced by 57.9% and 59.3%, respectively, in mAPP/PreP mice compared to single mAPP mice (Fig. 1B-C) . Interestingly, Aβ40 and Aβ42 levels were also significantly lower in cerebral cortex and hippocampus of mAPP/PreP compared to mAPP mice ( Fig. 1D-E) . Aβ immunoreactive plaque load was also reduced in the brain of mAPP/PreP mice but not in mAPP/PE mice ( Fig. 2SC-D) . Human Aβ was not found in mitochondrial fraction and cerebral cortex of Tg PreP, PE, and nonTg mice (data not shown). These data indicate that increased PreP expression attenuates both intramitochondrial and overall cerebral Aβ levels. 
Increased neuronal PreP expression ameliorates synaptic mitochondrial dysfunction
To determine whether reducing mitochondrial Aβ improves mitochondrial function. We first evaluated baseline mitochondrial respiratory function by measuring mitochondrial oxygen consumption and CCO enzymatic activity. The mitochondrial respiration control ratio (RCR) is an index of mitochondrial coupling, which reflects the efficacy of mitochondrial oxidative phosphorylation. Synaptic mitochondria from mAPP mice underwent a significant reduction in RCR compared to non-transgenic mice (Fig 2A) , whereas the RCR of mAPP/PreP mitochondria was significantly recovered (Fig. 2A) . Similarly, CCO enzyme activity in synaptic mitochondria of mAPP mice was decreased compared to non-transgenic littermate controls, whereas CCO activity was completely recovered in mAPP/PreP mitochondria (Fig. 2B) .
CCO activity and respiratory rates in non-transgenic mitochondria were comparable to PreP mitochondria, suggesting that increased PreP expression does not alter mitochondrial respiratory function under physiologic conditions. We then assessed brain mitochondrial energy metabolism by measuring brain ATP levels. Brain samples from mAPP mice had significantly reduced ATP levels compared to non-transgenic mice. In contrast, declines in ATP levels were largely reversed in mAPP/PreP mice (Fig. 2C) .
Increased PreP activity reduce oxidative stress
Because mitochondria are a major resource of ROS generation, we next assessed whether increased PreP expression attenuates ROS production in Aβ-affected brain. Consistent with our previous results (8) , brains of mAPP mice demonstrated remarkably increased MitoSox-Red, an indicator of mitochondrial superoxide, in terms of staining intensity of MitoSox-positive cells in hippocampus and cortex, indicating increased ROS accumulation in Aβ-loaded mitochondria. In contrast, MitoSox-Red signal was significantly suppressed in hippocampus and cortex of mAPP/PreP mice ( Fig. 2D-E) . There are no significant differences of MitoSox signals among nonTg, PreP, and PE group of mice (Fig. S3) . To further confirm the cerebral oxidative stress in mAPP mice, we quantitatively measured the intracellular ROS levels by a highly specific election paramagnetic resonance (EPR) spectroscopy in cortex. Compared to nonTg mice, the intracellular ROS levels were significantly elevated in mAPP brain, which was largely abolished in mAPP/PreP mice but not in mAPP/PE mice (Fig. 2F-G) . Together, these data suggest that increased PreP expression/activity attenuates mitochondrial ROS production and accumulation.
Effects of PreP on proinflammatory mediators in mAPP/PreP mice
Because mitochondria play an important role in proinflammatory signaling and dysfunctional mitochondria could potentiate inflammation and thus promotes cell death (27) , we hypothesize that protective effect of PreP on mitochondrial function may lessen inflammation in Aβ-affected brain. To test this concept, we first assessed expression levels of proinflammatory cytokines and chemokines in cortical tissue. Consistent with our previous studies (28) , mAPP mice showed a significant increase in cytokines (TNF-α and IL-1β) and chemokine MCP-1 compared to non-transgenic control mice. Notably, mAPP/PreP mice largely attenuated the production of these proinflammatory mediators ( Fig. 3A-C) . Given that receptor for advanced glycation end-product (RAGE) serves as an important cell-surface receptor-mediating chemotactic and inflammatory in response to Aβ and other proinflammatory ligands, we evaluated RAGE expression levels as well as microglial markers (CD4 and CD11b) in the brain. mAPP/PreP mice showed significant suppression of RAGE expression in addition to CD11b and CD4 as compared to mAPP mice ( Fig. 3D-F) . These results suggest the role of PreP in Aβ-mediated inflammation in addition to mitochondrial dysfunction.
Increased expression of neuronal PreP improves synaptic and behavioral function
Given that synaptic mitochondria are vital for maintenance of synaptic function and transmission, we examined synaptic transmission under basal conditions and during long-term potentiation (LTP), a form of synaptic plasticity that is widely studied as a cellular model for learning and memory. Hippocampal slices from 12-13-month-old non-transgenic control, PE and PreP mice showed similar levels of basal neurotransmission (field-excitatory post-synaptic potential, fEPSPs, Fig. S4A ) and LTP in the CA1 stratum radiatum (Fig. S4B) . However, basal synaptic transmission was significantly reduced in mAPP and mAPP/PE CA1 neurons compared to nonTg and mAPP/PreP CA1 neurons (Fig. S4C) . LTP recorded from CA1 neuron was significantly declined in mAPP mice compared those from nonTg mice. Slices from mAPP/PreP mice showed a largely restored LTP, but no such protection was found in mAPP/PE mice compared to mAPP mice ( Fig. 4A-B) . To determine the direct effect of PreP on Aβ-induced LTP deficit, we recorded LTP in hippocampal slices from PreP, PE, and control mice treated with Aβ. We found similar potentiation levels in PreP and PE slices compared to nonTg slices in the presence of vehicle. LTP was significantly reduced in control slices following treatment with 200 nM oligomeric Aβ42. However, PreP hippocampal slices were significantly resistant to Aβ-mediated deficits in LTP ( Fig. 4C-D) . Notably, PE slices were not protected from Aβ-mediated LTP reduction. Taken together, these data demonstrate that increased PreP expression/activity significantly alleviates synaptic damage in Aβ-rich brain.
We next examined whether PreP protection of synaptic activity also improves cognitive function.
Mice were first subjected to a spatial learning and memory test using a radial arm water maze. For spatial learning and memory tasks, single PreP, PE, and nonTg mice found the platform with 1-2 errors (Fig. S5A), showing good memory. Tg mAPP mice had 5-6 errors, whereas mAPP/PreP mice made significantly fewer errors (2-3 errors). In a retention memory test, mAPP/PreP mice showed significantly improved spatial reference memory conducted 30 min after trial (Fig. 5A) . We further assessed the spatial reference memory and target searching strategy using a Morris Water Maze (MWM). Compared to mAPP mice, mAPP/PreP mice revealed a shorter latency to locate the hidden platform during the training session ( Fig. 5B ) and increased the number of times crossing the target (Fig. 5C ) and time in the target quadrant (Fig. 5D ) in the recording period. In the Probe test, mAPP/PreP mice revealed an increased search activity in the quadrant where the hidden platform was located compared to mAPP mice. These results demonstrate that mAPP/PreP retained a better searching strategy. There was no significant difference in latency among PreP, PE, and nontransgenic mice (Fig. S5B) , indicating no effect of PreP overexpression on baseline spatial reference memory. The transgenic mice among tested groups had similar swimming speed by the visual swimming speed test (Fig. S5C-D) . Thus, the observed difference in spatial learning and memory is a result of defects in cognition but not motility or altered motivation. These data indicate that increased neuronal PreP expression and activity improves learning and memory in mAPP mice.
PreP proteolytic activity is essential for clearance of mitochondrial Aβ resulting in improved cognitive function
To further validate the role of PreP activity, we examined the inactive mutant form of PreP, which lacks PreP proteolytic activity on mitochondrial Aβ levels, synaptic mitochondrial function, synaptic plasticity, and learning and memory. Compared to mAPP/PreP mice, we did not observe any protective effects on human Aβ levels in mAPP/PE mitochondria and cerebral cortex in which mitochondrial Aβ levels were comparable to single mAPP mice (Fig. 1B-E) . As a result, there were no protective effects of mAPP/PE mice on RCR, CCO activity, ATP levels, and mitochondrial ROS generation and accumulation ( Fig. 2A-G) . Similarly, mAPP/PE mice did not suppress induction of inflammation and defects in LTP and behavior observed in mAPP mice (Fig. 3-5) . These results suggest that PreP proteolytic activity is essential for degradation and clearance of mitochondrial Aβ accumulation and maintenance of mitochondrial and synaptic function.
Effect of PreP on mitochondrial function and synaptic density in vitro cultured AD neurons
To determine the direct effect of neuronal PreP on Aβ-induced mitochondrial dysfunction and synaptic damage, we first analyzed mitochondrial function by measuring CCO activity and ATP levels in cultured hippocampal neurons derived from nonTg, mAPP, mAPP/PreP, and PreP mice. Neurons from mAPP mice revealed significant decline in CCO activity and ATP levels compared to nonTg neurons ( Fig.   6A-B) . The mAPP/PreP neurons reversed the deficits of CCO activity and ATP. Similarly, ROS levels in mAPP/PreP neurons were significantly lower than mAPP neurons ( Fig. 6C-D) . To assess the effect of PreP on synaptic alterations, we measured total length and synaptic density of neuronal dendrites. The mAPP/PreP neurons displayed an increase in length of dendrites compared to mAPP neurons (Fig. 6E, 6H-I ). Synaptic density was quantified by measuring synaptophysin (Syn, presynaptic marker) and glutamate receptor 1 (GluR1, post-synaptic marker) -positive clusters attaching to dendrites labeled with MAP2. The mAPP/PreP neurons increased both pre-and post-synaptic densities compared to mAPP neurons ( Fig. 6F-I) . These results suggest that increased PreP expression rescues Aβ-induced mitochondrial dysfunction and loss of synapses.
Discussion
In the present studies, we provide substantial evidence of the beneficial effect of PreP expression and activity, a mitochondrial Aβ scavenger, on rescuing AD-like mitochondrial and synaptic pathology as well as cognitive impairment in a transgenic AD mouse model. Our results illustrate that increased expression and activity of neuronal PreP significantly reduced mitochondrial Aβ load, improved mitochondrial function and synaptic plasticity and strength. As a result, cognitive function decline in AD mice was substantially attenuated by PreP overexpression. Notably, there is no protection in AD mice expressing comparable levels of non-functional mutant human PreP on Aβ-associated mitochondrial and synaptic pathology, suggesting that PreP proteolytic activity is required for degradation and clearance of mitochondrial Aβ. Furthermore, we unexpectedly found that increased PreP expression in mAPP mice significantly attenuates production of proinflammatory mediators.
Emerging evidence indicates that mitochondria are a target organelle of Aβ invasion. In AD patients and mouse models of AD, Aβ progressively accumulates in mitochondria and penetrates through mitochondrial membrane via mitochondrial protein transport machinery (29, 30) . The accumulation of Aβ in mitochondria is associated with increased ROS production, decreased mitochondrial membrane potential and ATP production, reduced mitochondrial calcium handling capacity, release of mitochondrial pro-apoptotic factors and defects in mitochondrial dynamics and motility (6, 11, 18, (31) (32) (33) (34) (35) (36) . Importantly, early accumulation of Aβ occurs in mitochondria at synapses, which might make synaptic mitochondria more vulnerable to Aβ toxicity (37) . Mitochondria maintain synaptic ion homeostasis and synaptic plasticity through producing ATP and controlling local Ca 2+ concentration. Aβ accumulation causes the impairment of mitochondrial transport and altered mitochondrial dynamics (9, 18, 38) . Aberrant mitochondrial function is associated with Aβ-altered synaptic structure and function such as loss of synapses and dendritic spines, preand post-synaptic proteins, and reduction of long-term potentiation (6, 8, 25, 26, 39, 40) . The early synaptic mitochondrial damage suggests that AD neurons may have already suffered harm for years, which may help explain the limitations to current amyloid hypothesis. Thus, strategies that suppress/attenuate Aβ-induced mitochondrial toxicity in addition to Aβ levels in the brain and improve cognitive function are critical for preventing and/or halting AD at a very early stage by improving mitochondrial function. Elimination of mitochondrial Aβ load could be an important strategy for rescuing mitochondrial and synaptic alterations. by which Aβ gains and accumulates in mitochondria will be explored in future studies.
We also unexpectedly observed that increased expression of PreP not only degrades mitochondrial
Aβ but also affects a total of brain Aβ levels, suggesting that mitochondrial Aβ is not just a "pilling over" from extracellular aggregation but also having an important regulating effect on the total brain Aβ levels. 
Given that exogenous or intracellular Aβ is capable of direct transport into mitochondria
In summary, we present a new insight into the role of mitochondrial PreP in neuronal mitochondrial
Aβ pathology and resultant mitochondrial and synaptic dysfunction relative to Aβ-rich AD mitochondria.
We clearly show that increased neuronal human PreP expression and activity in AD model significantly reduce mitochondrial and cerebral Aβ accumulation, suppress the induction of proinflammatory mediators, and improve synaptic mitochondrial function. Accordingly, we observe greatly improved synaptic transmission and spatial learning and memory in human disease phenotype of AD mouse model with neuronal PreP overexpression. These data support that the recently identified mitochondrial peptidasome, PreP, functions as a peptide scavenger, clearing off mitochondria of Aβ, and thereby protecting mitochondria against pathogenic peptide intruders. Thus, development of a small molecule PreP agonist (43) to upregulate PreP proteolytic activity that degrades Aβ would represent a novel therapeutic approach to improve mitochondrial and neuronal function by eliminating or at least decreasing steady-state mitochondrial Aβ levels, thereby halting AD progression at the early stage. into a Thy1 transgenic construct inserted into XhoI site (Fig. S1A) . Mutant form of hPreP (E107Q) (PE)
Materials and Method
Generation of transgenic (Tg) PreP mice.
were constructed using a QuikChange site-directed mutagenesis kit (Stratagene). Synaptic Mitochondria Preparation. Synaptic mitochondria preparation has been described previously (37, 52) . Briefly, brain cortices were placed in a 5× volume of ice-cold isolation buffer [225 mM mannitol, 75mM sucrose, 2mM K2PO4, 0.1% BSA, 5mM Hepes, 1mM EGTA (pH 7.
2)]. The tissue was homogenized with a Dounce homogenizer (Kontes Glass Co.). The resultant homogenates were centrifuged at 1,300 × g for 5 min, and the supernatant was layered on a 3 × 2-mL discontinuous gradient of 15%, 23%, and 40% (vol/vol) Percoll and centrifuged at 34,000 × g for 8 min. After centrifugation, band 2 (the interface between 15% and 23% containing synaptosomes) and band 3 (the interface between 23% and 40% containing nonsynaptic mitochondria) were removed from the density gradient. The fractions were then resuspended in 20 mL of isolation buffer containing 0.02% digitonin and incubated on ice for 10 min. The suspensions were then centrifuged at 16,500 × g for 15 min. The resulting loose pellets were washed for a second time by centrifugation at 8,000 × g for 10 min. Pellets were collected and resuspended in isolation buffer. A discontinuous Percoll density gradient centrifugation was performed as described above for a second time. Band 3 was obtained and resuspended in isolation buffer to centrifuge at 16,500 × g for 15 min. The resultant pellet was washed in isolation buffer at 8,000 × g for 10 min. The final synaptic mitochondrial pellet was resuspended in isolation buffer and stored on ice.
Protein concentration was determined using the Bio-Rad DC protein assay (BioRad Laboratories).
Cytosol Preparation. Brain tissues from the indicated transgenic mice were homogenized and subject to a centrifugation at 1,300 × g for 5 minutes to get rid of cell debris. The supernatant was then centrifuged at 10,000 × g for 10 minutes. The resultant supernatant was subjected to an ultracentrifugation at 100,000 × g for 1.5 hours and the supernatant was collected.
Immunofluorescent Staining: Brain slices from the indicated Tg mice were subjected to double immunestaining with rabbit anti-PreP IgG antibody (1:2,000) and mouse anti-Cytochrome C Oxidase (CCO) at 4°C overnight followed by the conjugation of goat anti-rabbit Alex488 and goat anti-mouse 594, respectively. The staining was checked and images were taken on a Leica Confocal Microscope.
Electron Microscopy. Ultrathin sections were incubated with rabbit anti-PreP IgG antibody (1:2,000) overnight at 4 °C; this was followed by conjugation of donkey anti-rabbit antibody to colloidal gold (18-nm gold particle) for 2 h at room temperature. Sections were counterstained with uranyl acetate and examined under EM (JEOL 100S) (37) .
Measurement of PreP proteolytic activity.
We used a fluorescence assay with fluorogenic substrate V (7-methoxycoumarin-4-yl-acetyl-NPPGFSAFK-2, 4-dinitrophenyl, R&D Systems) and measured the kinetics of proteolysis as previously described (43 at 550 nm was recorded immediately using a kinetic program with a 5-s delay, 10-s interval, and total of six readings on an Ultrospect 3100 Pro spectrophotometer as previously described (37) .
ATP levels. ATP levels were determined using an ATP Bioluminescence Assay Kit (Roche) following the manufacturer's instruction as we previously described (8, 53) . Briefly, the brain was quickly removed from anesthetic mice, slices of 1/4 cortex were immediately placed into liquid nitrogen, and then transferred to -80ºc freezer until use. The slices of cortex were homogenized in the lysis buffer provided, incubated on ice for 30 min, and centrifuged at 12,000g for 10 min. ATP levels were then measured in the subsequent supernatants using Luminescence plate reader (Molecular Devices). A 1.3 second delay time after substrate injection and 10 seconds integration time were used.
Evaluation of mitochondria and the intracellular reactive oxygen species (ROS) in Tg brain. Brain
sections from Tg mice were stained with Mitosox Red, a fluorochrome specific for anion superoxide produced in the inner mitochondrial compartment (Molecular Probes) for 30 minutes, and then images under confocal microscopy as described (8) . Quantification of staining intensity and the percentage of area occupied by Mitosox were performed using Universal image program (8) .
Evaluation of intracellular ROS levels was accessed by election paramagnetic resonance (EPR) spectroscopy as described in our previous study (54) . CMH (cyclic hydroxylamine 1-hydroxy-3-methoxycarbonyl-2,2,5,5-tetramethyl-pyrrolidine) (100μM) was incubated with hippocampal slices for 30 min, and then washed with cold PBS. The tissues were collected and homogenized with 100μl of PBS for EPR measurement. The EPR spectra were collected, stored, and analyzed with a Bruker EleXsys 540 xband EPR spectrometer (Billerica, MA) using the Bruker Software Xepr (Billerica, MA). Electrophysiological studies. Electrophysiological recordings were performed on transverse hippocampal slices (400 μm in thickness), as described (24, 55) . The hippocampal slices were maintained in an interface chamber at 29℃ and perfused with saline solution (124 mM NaCL, 4.4 mM KCL, 1 mM Na2HPO4, 25 mM NaHCO3, 2 mM CaCl2, 2.0 mM MgSO4, and 10 mM glucose) continuously bubbled with 95% O2 and 5% CO2. Field-excitatory post-synaptic potential (fEPSPs) was recorded from the CA1 region of the hippocampus by placing both the stimulating and the recording electrodes in the CA1 stratum radiatum. The basal synaptic transmission (BST) was assayed by plotting of the stimulus voltage (V) against slopes of fEPSP to generate input-output relations or by plotting of the peak amplitude of the fiber volley against the slope of the fEPSP to generate input-output relations. The long term potentiation (LTP) was induced using theta-burst stimulation (4 pulses at 100 Hz, with the bursts repeated at 5 Hz, and each tetanus, including 3 10-burst trains separated by 15 seconds).
Real-time PCR
Behavioral Test. Investigators were unaware of mouse genotypes until the behavioral tests were finished.
The radial arm water maze test was performed as we previously described (55) . The Morris Water Maze (MWM) test was performed according to the published method (56) . The apparatus mainly compose a pool, which is 150 cm in diameter and 50 cm in height, a platform placed in one of the fixed quadrant for mice to escape, and a camera above the center of the pool to capture the images of the swimming mice.
The tank is filled with water kept at 23 ± 2 ℃ during the trials. The platform is hidden 0.5-1 cm below the water surface and the white paint was used to better cover the platform. In spatial acquisition session, mice were trained for 6 consecutive days with 4 trial each mouse per day. A trial started with releasing one mouse facing the pool wall and the mouse was allowed to swim freely and search for the escape platform. If the mouse cannot reach the platform within 60s, it was guided to the platform and allowed to stay on for 15s before the next trial. After all trials, mice were dried with paper towel and returned to its own cage. The escape latency was analyzed by the behavior software system (HVS water 2020). On the day 7, a probe trial was performed to assess the spatial memory of mice. The platform was removed from the pool and the mice were allowed to swim freely for 60s. Traces of mice were recorded and data were analyzed by HVS water 2020.
Statistical Analysis. One-way ANOVA was used for repeated measure analysis, followed by Fisher's protected least significant difference for post hoc comparisons. P < 0.05 was considered significant.
StatView statistics computer software was used. All data were expressed as the mean ± SEM. 
